We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Preclinical Imaging Multimodality Software Module Developed

By MedImaging International staff writers
Posted on 11 Oct 2010
Print article
Software and accessory items have been designed to enable the direct coregistration of images from multiple preclinical imaging modalities.

Caliper Life Sciences, Inc. (Hopkinton, MA, USA), a provider of tools and services for drug discovery, life sciences research, and molecular diagnostics, introduced this toolkit, comprising the new Living Image multimodality software module and the Mouse Imaging Shuttle. The technology provides for integration of data from Caliper's IVIS (in vivo imaging system) optical imaging systems with data from Caliper's Quantum FX micro-computed tomography (CT) as well as data from third-party microCT, magnetic resonance imaging (MRI), positron emission tomography (PET), and single photon emission computed tomography (SPECT) instruments. Caliper provides a unique level of support by offering biologists a complete range of coregistration tools without the need for complex third-party software.

Coregistration allows researchers to overlay images from multiple imaging modalities, providing comprehensive insight into the molecular and anatomic features of an animal and its biology. For example, optical imaging data, which may be used to identify and quantify tumor burden at the molecular level, can be integrated with microCT data, which provides complementary anatomic detail and morphologic quantification.

With the Living Image Multi-Modality Software Module, researchers can directly import data from preclinical microCT, MRI, PET and SPECT into the Living Image software environment for combination with three-dimensional (3D) bioluminescence and fluorescence images from an IVIS Spectrum optical imaging system. The software contains sophisticated visualization features, and the Mouse Imaging Shuttle immobilizes the animal for transport between the different systems to enable high-quality coregistration. The multimodality kit has been optimized for use with Caliper's IVIS Spectrum and Quantum FX microCT imaging systems to enable comprehensive longitudinal imaging of a single animal over multiple time points without harming the subject. Living Image software is now distinctively capable of processing quantitative, functional optical data and integrating it with the anatomic views familiar to clinicians.

"Caliper's in vivo imaging solutions serve as a bridge between the laboratory and the clinic," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "Allowing researchers to layer images from a variety of imaging modalities enables a more a complete view of disease progression to help understand a compound's therapeutic potential sooner and progress drug candidates to clinical trials faster. Caliper is leading the market with our ability to not only generate extremely high quality 3D optical data and microCT images, but also to integrate images across a wide variety of platforms. This new coregistration toolkit is another component of our expansion strategy to address the [US]$500M preclinical imaging market."

Related Links:

Caliper Life Sciences



Ultrasound Imaging System
P12 Elite
New
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
New
Cylindrical Water Scanning System
SunSCAN 3D
New
Leg Wraps
Leg Wraps

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.